Aravive, Inc.
USD0.04
-0.01 (-13.39%)
CEO
Fredric N. Eshelman
IPO Date
2014-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.04
Prev. Close
$0.05
Day Low
$0.04
Day High
$0.05
52W Low
$0.04
52W High
$2.46
Market Cap
$0.00B
Volume
4.04M
| 700,000 |
| $1.67 |
| 27 Oct 2022 | Ho Peter Tai-Ching | director | A-Award | Acquired | 54,353 | $0.92 |
| 27 Oct 2022 | Ho Peter Tai-Ching | director | A-Award | Acquired | 27,177 | $0.00 |
| 27 Oct 2022 | Ho Peter Tai-Ching | director | A-Award | Acquired | 27,176 | $0.00 |
| 27 Oct 2022 | Zhang Eric | director | A-Award | Acquired | 543,537 | $0.92 |
| 27 Oct 2022 | Zhang Eric | director | A-Award | Acquired | 271,769 | $0.00 |
| 27 Oct 2022 | Zhang Eric | director | A-Award | Acquired | 271,768 | $0.00 |
| 26 Oct 2022 | HOWARD RUDY | Chief Financial Officer | A-Award | Acquired | 10,870 | $0.92 |
| 26 Oct 2022 | HOWARD RUDY | Chief Financial Officer | A-Award | Acquired | 5,435 | $0.00 |